Horse Allergy Shots: Occupational Severity and the Lipocalin Triad
Horse allergy is underestimated in severity — reactions routinely include anaphylaxis and angioedema within minutes (Roberts & Lack, BMJ 2000). The major allergen Equ c 1 (50-76% sensitization) anchors the cat-dog-horse lipocalin triad. No FDA-standardized horse extract exists; SCIT evidence is case-series level rather than RCT.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Horseis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Horse Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to horse — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of horse allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of horse immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of horse extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for horse allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing horse extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription horse immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat horse allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Horse?
The biology, taxonomy, and clinical fingerprint of Horse — the foundation of how SCIT targets it.
Horse allergen travels via clothing — classrooms showed allergen levels correlated with the proportion of students with equine leisure contact (Merritt et al., ISRN Allergy 2011). Sweden recommends 500 m between stables and schools.
- Scientific name
- Equus caballus
- Family
- EquidaeHorse family
- Type
- Occupational and avocational animal dander allergen
- Native to
- Central Asia (ancestral range); domesticated worldwide ~4,000 BCE
- Allergen proteins
- Equ c 1 (major) — 25 kDa glycosylated lipocalin homodimer; 50-76% sensitization (Saarelainen et al., 2008: 76%)Equ c 2 — 17 kDa lipocalin; ~33% sensitizationEqu c 3 — 67 kDa serum albumin; 32-50% sensitization; cross-reacts with cat Fel d 2, dog Can f 3, cow Bos d 6Equ c 4 — 17-20 kDa latherin (PLUNC-family surfactant); 77% sensitization (Goubran Botros et al., 2001); proposed marker of genuine horse sensitizationEqu c 6 — lysozyme, ~15 kDa; limited characterization (Martini et al., 2018)
- Particle size
- Variable; stable dust particles can remain airborne for hours in enclosed barn environments
- Avoidance difficulty
- Very difficult
How Horse Allergy Presents
Symptoms by body system — useful for distinguishing Horse sensitivity from overlapping allergies and infections.
Respiratory
- Acute asthma within minutes of entering a stable or mounting a horse (Roberts & Lack, BMJ 2000)
- Nasal congestion and rhinorrhea with rapid onset — often more dramatic than cat or dog allergy
- Persistent occupational asthma in equestrian professionals with years of cumulative sensitization
- Asthma triggered by a classmate's riding clothing stored in a shared bedroom (documented by Roberts & Lack, 2000)
- Bronchospasm from indirect exposure in enclosed spaces with poor ventilation
Ocular
- Acute conjunctivitis and lacrimation within minutes of barn entry
- Periorbital swelling with concentrated allergen exposure
- Eye symptoms often accompanying severe respiratory reactions in equestrian-allergic patients
- Persistent ocular allergy in barn workers with cumulative daily exposure
Dermal
- Contact urticaria after direct contact with horse hair or sweat
- Angioedema documented in acute anaphylaxis events (SpO2 drops to 90% within minutes; Roberts & Lack, 2000)
- Eczema flare in atopic individuals with regular grooming exposure
- Hive formation after touching grooming equipment or tack without direct animal contact
Systemic
- Anaphylaxis — more frequently documented with horse than with cat or dog allergy, often within minutes of mounting
- Life-threatening reactions documented from horse-derived antivenoms (ANAVIP) in sensitized patients (case report, PubMed 40874868, 2025)
- Severe occupational disability when sensitization forces career change in professional equestrians
- Fatigue and cognitive impairment in stablehands with chronic daily low-level exposure
Horse allergy is the one I worry about more than cat or dog. The reactions are bigger — stables are concentrated environments — and patients often present after years of daily work around horses with a sudden severe event. Many cannot change careers. SCIT here is about enabling continued occupational exposure, not casual pet contact, and we have to set expectations: the evidence base is much smaller than for cat.
Where Horse Triggers Year-Round
Horse is a perennial trigger — exposure is constant for sensitized patients. Geographic intensity still varies by climate.
12-Month Intensity
Year-roundPerennial with seasonal increase in spring through fall when outdoor riding and equestrian competition seasons are most active.· Year-round in indoor barn settings; indirect exposure via allergen-contaminated clothing persists in schools and homes throughout the year.
US Exposure Map
20 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- High
- MT:
- High
- ND:
- Low
- MN:
- Moderate
- WI:
- Moderate
- MI:
- Moderate
- NY:
- Moderate
- MA:
- Moderate
- OR:
- High
- ID:
- High
- WY:
- High
- SD:
- Low
- IA:
- Moderate
- IL:
- Moderate
- IN:
- High
- OH:
- High
- PA:
- High
- NJ:
- Moderate
- CT:
- Moderate
- RI:
- Low
- CA:
- High
- NV:
- Moderate
- UT:
- Moderate
- CO:
- High
- NE:
- Moderate
- MO:
- Moderate
- KY:
- High
- WV:
- Low
- VA:
- High
- MD:
- High
- DE:
- Low
- AZ:
- Moderate
- NM:
- Moderate
- KS:
- Moderate
- AR:
- Moderate
- TN:
- High
- NC:
- High
- SC:
- High
- OK:
- High
- LA:
- Moderate
- MS:
- Moderate
- AL:
- Moderate
- GA:
- High
- TX:
- High
- FL:
- High
- AK:
- Low
- HI:
- Low
What Horse Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Equ c 1 is the cornerstone of the cat-dog-horse lipocalin triad — the most clinically significant cross-reactivity network in pet allergy. Up to 73.8% of horse-sensitized dog-allergic patients are co-sensitized to all three species through shared lipocalin epitopes (Hilger et al., JACI 2012).
Equ c 1 ↔ Fel d 4 lipocalin (~67% identity); Equ c 3 ↔ Fel d 2 albumin — patient may have primary cat sensitization cross-reacting to horse
Is SCIT Right for Your Horse Allergy?
Answer five questions to assess whether horse allergy shots are appropriate for your occupational or recreational situation.
How severe are your reactions when exposed to horses?
The Horse SCIT Protocol
Horse SCIT uses non-FDA-standardized whole-body epithelial extract — avoidance is the preferred first-line approach when feasible; SCIT is reserved for equestrian professionals and committed riders for whom avoidance is practically impossible.
Incremental dose escalation from highly diluted starting concentrations. Patients must be observed for 30 minutes after each injection. For equestrian professionals, the allergist may recommend a pre-competition dosing schedule to avoid peak training disruption. Counsel patients about hidden exposures: horsehair mattresses, upholstery, horse-derived gelatin products, and equine antitoxin or antivenom products.
Maintenance injections are continued for 3-5 years. Unlike cat SCIT where FDA-standardized extract ensures dosing precision, horse extract variability means clinical response monitoring is especially important. Regular symptom assessment and peak-flow monitoring for asthmatic patients are recommended at maintenance visits.
Discontinuation decisions for horse SCIT depend on occupational exposure level. Professional equestrians with ongoing daily barn exposure may require extended or indefinite maintenance rather than a definitive course end.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Horse SCIT
Horse SCIT evidence is based primarily on case series and expert opinion rather than double-blind RCTs — a gap that should be communicated honestly to patients.
- Symptom improvement in equestrian worker cohort (case series)50%Expert opinion extrapolated from Cox et al., JACI 2011 Practice Parameter framework; no horse-specific DBPC-RCT identified
- Prevalence reduction with occupational controls (PPE, ventilation)60%NIOSH Alert 97-116 (1998); environmental controls in occupational settings — not SCIT-specific data
No published double-blind placebo-controlled RCT specifically studying horse SCIT has been identified in the literature. Clinical use is extrapolated from the general AAAAI/ACAAI Practice Parameter framework (Cox et al., JACI 2011) and from the broader animal-dander SCIT evidence base led by cat and dog studies. For equestrian professionals with no avoidance option, SCIT is a clinically reasonable intervention that some allergists recommend, but patients should understand that the evidence is substantially thinner than for cat or grass immunotherapy.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Horse SCIT Side Effects
Horse SCIT side effects follow the general pattern of inhalant allergen SCIT, though non-standardized extract may increase variability in local reaction severity.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheal and flare at injection site; typically resolves within 30-60 minutes | Rate 30-50% | Mild |
Injection-site itching | Rate 20-40% | Mild |
Large local reaction (>25 mm wheal) More variable with non-standardized extract; may require dose adjustment | Rate 5-15% | Moderate |
Delayed local reaction (4-8 hours) | Rate 5-15% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Generalized urticaria | Rate 0.1-0.5% per injection | Moderate |
Rhinitis/conjunctivitis flare | Rate 0.2-0.5% | Mild |
Bronchospasm Important to confirm stable baseline asthma before each injection for asthmatic patients | Rate 0.1-0.2% | Moderate |
Anaphylaxis Very rare; epinephrine confirmed on hand at the injection location; 30-minute observation is mandatory | Rate <0.01% per injection | Severe |
Traditionally horse SCIT was given only in a clinic, but for eligible patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff; reactions typically begin within ~30 minutes, so a brief post-injection self-observation is advised. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. Equestrian patients with a history of severe anaphylactic reactions from horse exposure require especially careful build-up pacing and asthma control confirmation at every visit.
SCIT vs Alternatives for Horse
Horse-allergic patients who cannot avoid exposure have three main treatment options: SCIT (non-standardized extract, case-series evidence), at-home SLIT drops (off-label), and aggressive medications plus engineering controls (stable ventilation, PPE).
| Criterion | SCITBest | SLIT | Avoidance | Medications + PPE |
|---|---|---|---|---|
| Effectiveness | Moderate — case series evidence only | Off-label; less direct evidence than for cat | Complete if feasible | Partial — reduces symptom burden |
| 5-yr cost | $3,500-$10,000 | Varies by provider (off-label drops) | $0 | $500-$2,000/yr |
| Duration | 3-5 years | 3-5 years | Permanent | Indefinite |
| Convenience | Self-administered weekly at home with Curex (build-up) | Daily drops at home | Not possible for professionals | N95 + antihistamines daily |
| Safety | Very safe; Curex confirms prescribed epinephrine on hand and supervises the first injection from each new vial or concentration live in the Virtual Shot Room | Very safe; no clinic required | No side effects | Generally safe |
| Lasting effect | Some sustained benefit post-course | Ongoing benefit while continuing | Permanent if strict | No lasting effect after stopping |
SCITBest
SLIT
Avoidance
Medications + PPE
For equestrian professionals who cannot leave the trade, SCIT — despite limited RCT evidence — is the most evidence-forward approach for modifying the underlying allergen response. Curex delivers that same immunotherapy as a weekly shot you give yourself at home with pricing confirmed in a current program quote, ideal for riders whose competition schedules make weekly clinic appointments impractical — a personalized serum sterile-compounded to USP <797>, the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand.
What Horse SCIT Actually Costs
Most major US health insurers cover horse SCIT under standard allergy benefits when prescribed by a board-certified allergist for confirmed horse sensitization. Non-standardized extract status does not typically prevent coverage eligibility. Prior authorization requirements vary. Out-of-pocket costs depend on deductible, co-insurance percentage, and whether occupational allergen immunotherapy has specific coverage tier designations in your plan. Curex at-home IgE testing identifies specific horse sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your horse allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Horse SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Horse allergy reactions tend to be more severe for several reasons. First, stables are highly concentrated allergen environments — enclosed spaces with large animals, abundant dander, and reduced ventilation. Second, the Equ c 4 (latherin) allergen, with 77% sensitization, is a surfactant protein present in high concentrations in horse sweat and saliva, creating intense acute allergen challenge. Third, many horse-allergic patients are occupationally sensitized over years before recognizing the allergy — by which time IgE levels are high and reactions are severe. Roberts and Lack (BMJ 2000) documented cases of angioedema with SpO2 drops to 90% within minutes of mounting — a severity rarely seen with cat or dog allergy.
Yes — indirect horse allergen exposure is well-documented. Equ c 1 is transported via clothing: a classmate who rides horses can bring sufficient allergen into a classroom to trigger reactions in sensitized children. Roberts and Lack (BMJ 2000) documented asthma triggered in a child solely by his sister's riding gear stored in a shared bedroom. Swedish health authorities recommend a minimum 500-meter distance between stables and schools to reduce this indirect exposure. Horsehair in mattresses, upholstery, and old stuffed animals can also accumulate and release allergens over time. If you have unexplained perennial respiratory symptoms without obvious animal contact, indirect horse exposure is a legitimate consideration.
The lipocalin triad is the molecular cross-reactivity connection between horse (Equ c 1), cat (Fel d 4), and dog (Can f 6) allergens. These three lipocalin proteins share 55-67% amino acid sequence identity, meaning IgE antibodies raised against one can cross-react with the others. Hilger et al. (JACI 2012) found that among horse-sensitized dog-allergic patients, 73.8% were co-sensitized to all three species. The clinical implication: a patient presenting with apparent horse allergy may actually be primarily cat-sensitized, with cross-reactive Fel d 4 IgE triggering reactions to the horse's Equ c 1. Component-resolved testing (measuring Equ c 1, Equ c 4, Equ c 3 vs Fel d 1, Fel d 4) identifies which species is the primary sensitizer and thus which immunotherapy target makes the most sense.
Yes — this is a genuine emergency-medicine concern. Several antivenoms and antitoxins (including ANAVIP, a horse-derived viper antivenom) are manufactured from immunized horse serum. In horse-sensitized patients, administration of horse-derived biological products can cause severe or fatal anaphylaxis. A 2025 case report (PubMed 40874868) documented life-threatening anaphylaxis from horse-derived antivenom in a horse-sensitized patient. Medical alert documentation of horse allergy is important, and emergency providers should be informed before any equine-derived biological is administered. Alternative human-derived or recombinant antivenoms should be considered for horse-sensitized patients when clinically appropriate.
The key differences are extract quality and evidence strength. Cat SCIT uses FDA-standardized cat-hair extract (10,000 BAU/mL) with three published double-blind RCTs and real-world 85-90% improvement data. Horse SCIT uses non-standardized extract — potency varies between manufacturers — with no published double-blind RCT. For cat allergy, three distinct double-blind placebo-controlled trials confirm efficacy; for horse, clinical use extrapolates from the general Practice Parameter framework and case series. In terms of severity, horse allergy more commonly causes anaphylaxis; in terms of treatment, cat allergy has the stronger immunotherapy evidence. This doesn't mean horse SCIT is ineffective — it means patients need more honest counseling about the evidence gap.
Yes — horse SCIT is a reasonable option for pediatric equestrians with confirmed Equ c 1 sensitization whose symptoms are not manageable with medications and who cannot stop riding. The general SCIT protocols apply: children typically start from age 5-6 upward, stable baseline asthma is required before initiating, and a board-certified allergist supervises the full protocol. Given the sparse RCT evidence for horse SCIT specifically, the allergist should first rule out primary cat sensitization driving cross-reactive horse allergy (very common in the lipocalin triad), which would redirect the immunotherapy target. Pre-SCIT component testing is especially important in pediatric patients. Note: the Curex at-home pilot is currently open to patients age 12 and older; pediatric patients require a trained adult caregiver physically present for every injection.
Yes — horse allergen exposure extends well beyond direct horse contact. Horsehair mattresses and upholstered furniture can accumulate and release Equ c 1 for years after manufacture. Horse-derived gelatin (used in some pharmaceuticals, gummy candies, and marshmallows) contains trace horse proteins — in severely sensitized patients this may be relevant. Most significantly, horse-derived antivenoms and antitoxins (ANAVIP for viper envenomation, some equine antitoxins for botulism) can cause anaphylaxis in horse-sensitized patients. Riding gear — helmets, gloves, saddles — retains allergen and can trigger reactions when handled by non-riding family members. Sweden's 500-meter stable-to-school distance recommendation reflects classroom allergen contamination via students' clothing as a genuine exposure risk.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.